NEXTCURE, INC Other Current Liabilities
NEXTCURE, INC (NXTC) had Other Current Liabilities of $135.00 thousand as of 2025-12-31, per its S-4 filed 2026-08-18.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-18
- 2025-12-31: Other Liabilities, Current $135.00K.
- 2024-12-31: Other Liabilities, Current $124.00K.
- 2023-12-31: Other Liabilities, Current $113.00K.
- 2022-12-31: Other Liabilities, Current $105.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2025-12-31 | $135.00K S-4 · filed 2026-08-18 |
| 2024-12-31 | $124.00K S-4 · filed 2026-08-18 |
| 2023-12-31 | $113.00K 10-K · filed 2025-03-06 |
| 2022-12-31 | $105.00K 10-K · filed 2024-03-21 |
| 2021-12-31 | $217.00K 10-K · filed 2023-03-02 |
| 2020-12-31 | $13.00K 10-K · filed 2022-03-03 |
| 2019-12-31 | $154.00K 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |